thiophenes has been researched along with Neointima in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Duthie, KM; Hadoke, PW; Ivy, JR; Kirkby, NS; Lim, WG; McShane, JF; Miller, E; Webb, DJ | 1 |
| Bai, HY; Chisaka, T; Higaki, A; Higaki, J; Horiuchi, M; Iwanami, J; Kanno, H; Kukida, M; Min, LJ; Mogi, M; Nakaoka, H; Ohshima, K; Okura, T; Shan, BS; Tsukuda, K; Wang, XL; Yamauchi, T | 1 |
2 other study(ies) available for thiophenes and Neointima
| Article | Year |
|---|---|
Selective endothelin A receptor antagonism with sitaxentan reduces neointimal lesion size in a mouse model of intraluminal injury.
Topics: Animals; Disease Models, Animal; Endothelin A Receptor Antagonists; Endothelin B Receptor Antagonists; Femoral Artery; Isoxazoles; Male; Mice; Mice, Inbred C57BL; Muscle Contraction; Muscle, Smooth, Vascular; Myography; Neointima; Pyrrolidines; Thiophenes | 2015 |
Angiotensin II Type 2 Receptor Inhibits Vascular Intimal Proliferation With Activation of PPARĪ³.
Topics: Animals; Carrier Proteins; Male; Mice, Inbred C57BL; Myocytes, Smooth Muscle; Neointima; PPAR gamma; Receptor, Angiotensin, Type 2; Sulfonamides; Thiophenes; Tumor Suppressor Proteins; Vascular Remodeling | 2016 |